SuperSonic Imagine announced that it will unveil its latest innovations for the first time at the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place, Chicago, December 1-6. The RSNA, which is the premier annual radiology forum in the world, hosts over 50,000 attendees every year, including almost 30,000 healthcare professionals. The conference provides an opportunity to showcase the latest technology and innovative techniques in medical imaging. SuperSonic Imagine was recently acquired by Hologic, Inc, an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. RSNA will be the first time that SuperSonic Imagine and Hologic will jointly present their innovative solutions for women's health at SuperSonic Imagine Booth #2324 and Hologic Booth #2511. SuperSonic Imagine. The latest version, introduced under the name of ShearWave PLUS, is the only technique that can visualize, analyze and quantify tissue stiffness in real time. This revolutionary technique, that is now widely endorsed by radiologist community and which is available on the Aixplorer MACH 30, has changed how ultrasound exams are performed on a daily basis. It has furthermore become a standard for characterization of breast lesions. This first mode was followed by other innovative imaging modes such as Angio PL.U.S. (PLanewave UltraSensitive imaging), TriVu and more recently the Needle PL.U.S. that makes it possible to visualize the needle with unparalleled precision and predict its trajectory, thereby allowing to perform biopsies with confidence. SuperSonic Imagine, a major actor promoting innovation in ultrasound, will introduce a suite of three ultrasound markers for non-invasive assessment of the severity of chronic liver diseases with quantitative results: Att PLUS, SSp PLUS and Vi PLUS. The first two of these tools allow for the simultaneous quantification of ultrasound attenuation in the liver and intrahepatic sound speed, reflecting fat content, an essential criterion for the detection and diagnosis of hepatic steatosis. Coupled with elasticity imaging in real time, the third one, Vi PLUS, makes it possible to visualise and quantify tissue viscosity, providing clinicians with important information for tissue characterization.